On today’s episode, we review current management of diabetic retinopathy with vitreoretinal surgeon Dr. Andrew Barkmeier and discuss new research on the impact of novel T2D GLP-1 RA and SGLT2i medications on diabetic retinopathy.
Subscribe to the podcast: https://mayoclinicophthalmology.podbean.com
Follow and reach out to us on IG and X: @mayocliniceye
